452 related articles for article (PubMed ID: 17902729)
1. Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy.
DuBuske L
Am J Clin Dermatol; 2007; 8(5):271-83. PubMed ID: 17902729
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial.
Ortonne JP; Grob JJ; Auquier P; Dreyfus I
Am J Clin Dermatol; 2007; 8(1):37-42. PubMed ID: 17298105
[TBL] [Abstract][Full Text] [Related]
3. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB
J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients.
Augustin M; Ehrle S
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):292-9. PubMed ID: 19438819
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies.
Bachert C; Maurer M
Clin Drug Investig; 2010; 30(2):109-22. PubMed ID: 20067329
[TBL] [Abstract][Full Text] [Related]
6. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
Ring J; Hein R; Gauger A; Bronsky E; Miller B
Int J Dermatol; 2001 Jan; 40(1):72-6. PubMed ID: 11277962
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients.
Potter PC; Kapp A; Maurer M; Guillet G; Jian AM; Hauptmann P; Finlay AY
Allergy; 2009 Apr; 64(4):596-604. PubMed ID: 19053988
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial.
Monroe E; Finn A; Patel P; Guerrero R; Ratner P; Bernstein D;
J Am Acad Dermatol; 2003 Apr; 48(4):535-41. PubMed ID: 12664016
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review.
Devillier P; Roche N; Faisy C
Clin Pharmacokinet; 2008; 47(4):217-30. PubMed ID: 18336052
[TBL] [Abstract][Full Text] [Related]
10. Safety of desloratadine syrup in children.
Bloom M; Staudinger H; Herron J
Curr Med Res Opin; 2004 Dec; 20(12):1959-65. PubMed ID: 15701213
[TBL] [Abstract][Full Text] [Related]
11. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Paradiso MT; Ferrannini A
Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373
[TBL] [Abstract][Full Text] [Related]
12. Desloratadine: an update of its efficacy in the management of allergic disorders.
Murdoch D; Goa KL; Keam SJ
Drugs; 2003; 63(19):2051-77. PubMed ID: 12962522
[TBL] [Abstract][Full Text] [Related]
13. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled study.
Grob JJ; Auquier P; Dreyfus I; Ortonne JP
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):87-93. PubMed ID: 18181978
[TBL] [Abstract][Full Text] [Related]
15. [Desloratadine for chronic idiopathic urticaria].
Rottem M; Elbirt D; Sthoeger Z;
Harefuah; 2005 Aug; 144(8):547-53, 599, 598. PubMed ID: 16146151
[TBL] [Abstract][Full Text] [Related]
16. The safety and efficacy of desloratadine for the management of allergic disease.
Berger WE
Drug Saf; 2005; 28(12):1101-18. PubMed ID: 16329713
[TBL] [Abstract][Full Text] [Related]
17. Desloratadine.
McClellan K; Jarvis B
Drugs; 2001; 61(6):789-96; discussion 797. PubMed ID: 11398910
[TBL] [Abstract][Full Text] [Related]
18. Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years.
Potter P; Mitha E; Barkai L; Mezei G; Santamaría E; Izquierdo I; Maurer M
Pediatr Allergy Immunol; 2016 Feb; 27(1):55-61. PubMed ID: 26267219
[TBL] [Abstract][Full Text] [Related]
19. H1-antihistamines for chronic spontaneous urticaria.
Sharma M; Bennett C; Cohen SN; Carter B
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD006137. PubMed ID: 25397904
[TBL] [Abstract][Full Text] [Related]
20. Adult and paediatric poor metabolisers of desloratadine: an assessment of pharmacokinetics and safety.
Prenner B; Kim K; Gupta S; Khalilieh S; Kantesaria B; Manitpisitkul P; Lorber R; Wang Z; Lutsky B
Expert Opin Drug Saf; 2006 Mar; 5(2):211-23. PubMed ID: 16503743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
